Skip to main content
Back to RA Capital Management

RA Capital Management's Clinical Trials Portfolio

Browse 10 Clinical Trials companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Clinical Trials Companies
10
Total Funding in Clinical Trials
$823.8M

Clinical Trials Portfolio Companies (10)

Export
BiotechnologyClinical TrialsHealth CareTherapeutics

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

San Francisco, United States
September 2026
$92.5M
Series E

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsGeneticsHealth CareLife ScienceMedicalPharmaceuticalTherapeutics

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

Cambridge, United States
September 2026
$56.3M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsTherapeutics

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Sioux Falls, United States
March 2026
$85.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth CarePharmaceutical

ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.

New York, United States
February 2026
$115.0M
Series D

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsOncology

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

Culver City, United States
October 2025
$96.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsMedical

PepGen is empowering nucleic acid therapeutics to go the distance.

Oxford, United Kingdom
September 2025
$115.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Clinical Trials

Pahr Therapeutics is a clinical stage business, is to create innovative ways to treat pulmonary arterial hypertension.

Boston, United States
July 2025
$14.0M
Seed

Founder Contacts

41,000+ verified contacts

Clinical TrialsHealth CareMedical Device

Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology

Ness Ziona, Israel
October 2024
$28.5M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsTherapeutics

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

New York, United States
January 2024
$172.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsPharmaceutical

CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.

Chevy Chase, United States
May 2018
$49.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio